High expression of CD47 predicts adverse prognosis in Chinese patients and suppresses immune response in melanoma

被引:21
|
作者
Fu, Wenhua [1 ]
Li, Jisen [1 ]
Zhang, Wei [1 ]
Li, Peng [1 ]
机构
[1] Peoples Hosp Weifang, Dept Cosmet & Plast Surg, 151 Guangwen St, Weifang, Shandong, Peoples R China
关键词
CD47; Melanoma; Prognosis; Survival; Immune response; CANCER; IMMUNOTHERAPY; DESTRUCTION; INHIBITION; TARGET; TUMORS; CELLS; BRAF;
D O I
10.1016/j.biopha.2017.06.030
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background: Cluster of differentiation 47 (CD47) negatively regulates macrophage phagocytosis and is correlated with adverse survival of multiple cancers. In melanoma patients, especially in Chinese melanoma patients, its prognostic value is unclear. In this study, we aim to study the prognostic value of CD47 in a Chinse melanoma patient cohort and its immunomodulation roles in mouse model. Method: 164 melanoma tissue specimens were collected. The expression of CD47 in these clinical samples was examined by immunohistochemistry staining (IHC). The correlation between CD47 expression and clinicopathological parameters was assessed by statistical analysis. Prognostic values CD47 expression were also investigated. In an animal model, effects of CD47 expression on immune infiltration were examined. Results: CD47 expression was positively correlated with TNM stage, distant metastasis, and death of melanoma patients with the P value of 0.008, 0.018, and 0.032 respectively. High expression of CD47 was an independent prognostic marker of overall survival (HR = 1.563, 95% CI: 1.069-2.285) and progression free survival (HR = 1.542, 95% CI: 1.053-2.258) of Chinese melanoma patients. Conclusion: In conclusion, high expression of CD47 predicted poor survival in a Chinese melanoma patient cohort and impaired antitumor immune response in the animal model. Targeting CD47 might be a novel option for melanoma patients. (C) 2017 Published by Elsevier Masson SAS.
引用
收藏
页码:1190 / 1196
页数:7
相关论文
共 50 条
  • [1] TIGIT/CD47 dual high expression predicts prognosis and is associated with immunotherapy response in lung squamous cell carcinoma
    Peng, Yue
    Qiu, Bin
    Tan, Fengwei
    Xu, Jiachen
    Bie, Fenglong
    He, Huayu
    Liu, Lei
    Tian, He
    Bai, Guangyu
    Zhou, Bolun
    Li, Yuan
    Huai, Qilin
    Yang, Zhenlin
    Gao, Shugeng
    THORACIC CANCER, 2022, 13 (14) : 2014 - 2023
  • [2] Correlation of CD47 Expression with Adverse Clinicopathologic Features and an Unfavorable Prognosis in Colorectal Adenocarcinoma
    Kim, Hyunsung
    Jee, Seungyun
    Kim, Yeseul
    Sim, Jongmin
    Bang, Seongsik
    Son, Hwang Kyu
    Park, Hosub
    Myung, Jaekyung
    Ko, Young Hyeh
    Paik, Seung Sam
    DIAGNOSTICS, 2021, 11 (04)
  • [3] CD47 Expression and Prognosis in a Cohort of Patients with Lung Adenocarcinoma (NSCLC)
    Arrieta, O.
    Orozco-Morales, M.
    Cardona, A.
    Aviles, A.
    Hernandez-Pedro, N.
    Cabrera-Miranda, L.
    Soca-Chafre, G.
    Barrios, P.
    Cruz-Rico, G.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2011 - S2011
  • [4] MAPK REGULATES CD47 EXPRESSION IN MELANOMA CELLS
    Liu, Fen
    Tseng, Cindy Hsin-Yi
    Jin, Lei
    Zhang, Xu Dong
    Jiang, Chen Chen
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2016, 12 : 26 - 26
  • [5] CD52 mRNA expression predicts prognosis and response to immune checkpoint blockade in melanoma
    de Vos-Hillebrand, Luka
    Fietz, Simon
    Hillebrand, Philip
    Kulcsar, Zsofi
    Diop, Marie Yatou
    Hollick, Sarah
    Maas, Alexander Philippe
    Strieth, Sebastian
    Landsberg, Jennifer
    Dietrich, Dimo
    PIGMENT CELL & MELANOMA RESEARCH, 2024, 37 (02) : 309 - 315
  • [6] The DNA damage response pathway regulates the expression of the immune checkpoint CD47
    Ghantous, Lucy
    Volman, Yael
    Hefez, Ruth
    Wald, Ori
    Stern, Esther
    Friehmann, Tomer
    Chajut, Ayelet
    Bremer, Edwin
    Elhalel, Michal Dranitzki
    Rachmilewitz, Jacob
    COMMUNICATIONS BIOLOGY, 2023, 6 (01)
  • [7] The DNA damage response pathway regulates the expression of the immune checkpoint CD47
    Lucy Ghantous
    Yael Volman
    Ruth Hefez
    Ori Wald
    Esther Stern
    Tomer Friehmann
    Ayelet Chajut
    Edwin Bremer
    Michal Dranitzki Elhalel
    Jacob Rachmilewitz
    Communications Biology, 6
  • [8] CD47 Expression and Prognosis in Patients with Small Cell Lung CancerCD47 Expression and Prognosis in Patients with Small Cell Lung Cancer
    Hernandez-Pedro, N.
    Orozco-Morales, M.
    Aviles-Salas, A.
    Cabrera-Miranda, L.
    Ramirez-Tirado, L.
    Barrios-Bernal, P.
    Arrieta, O. G.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S1022 - S1022
  • [9] CD47 expression in non-melanoma skin cancers
    Abbas, O.
    Kurban, M.
    MELANOMA RESEARCH, 2016, 26 : E63 - E63
  • [10] Correlated Intrinsic Breast Cancer Subtypes and Expression of CD47 in BM and PB Predicts Poor Prognosis
    Nagahara, M.
    Sugihara, K.
    Mori, M.
    ANNALS OF SURGICAL ONCOLOGY, 2014, 21 : S55 - S55